Skip to content

Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology

Home
Uncategorized
Corvus surges as lead asset advances to mid-stage trial in eczema

Corvus surges as lead asset advances to mid-stage trial in eczema

Jan 20, 2026

Post navigation

Illumina secures CMS reimbursement for TruSight™ Oncology Comprehensive, expanding access to precision oncology

Worldwide Clinical Trials adds Catalyst Clinical to global CRO mixture

PR Newswire
GlobeNewswire

Contact
Privacy Policy

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

Search for: